To investigate whether SOX2 potentially mediated PCAT1‐induced immune modulation in NSCLC, we explored the impacts of SOX2 via performing the GSEA in TCGA data set of NSCLC. This evidence concerns the gene SOX2 and non-small cell lung carcinoma.